Advertisement
U.S. markets close in 5 hours 8 minutes

Daxor Corporation (DXR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
8.57+0.19 (+2.27%)
As of 04:00PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close8.38
Open8.70
Bid7.50 x 800
Ask8.89 x 1000
Day's Range8.57 - 8.57
52 Week Range7.11 - 13.13
Volume10
Avg. Volume3,081
Market Cap41.19M
Beta (5Y Monthly)-0.49
PE Ratio (TTM)61.21
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 05, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-28% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DXR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Daxor Corporation
    Analyst Report: Edwards Lifesciences CorporationSpun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
    Rating
    Fair Value
    Economic Moat
    3 years agoMorningstar
View more